Ghaemmaghami Fatemeh, Karimi Zarchi Mojgan
Tehran University of Medical Sciences, Tehran, Iran;
Int J Biomed Sci. 2008 Mar;4(1):74-7.
Choriocarcinoma is a curable malignancy that occurred approximately 50% after term pregnancies, and prognosis in this form of gestational trophoblastic Disease (GTD) is Poor. The earliest onset choriocarcinoma after term pregnancy in one study was reported 3 weeks after delivery, but in current study, choriocarcinoma was diagnosed 2 weeks after delivery. 28 years-old women gravidity 2, parity 2 delivered a healthy infant at term. Frequent episodes of vaginal bleeding occurred after 10 days of delivery. On admission to hospital, she had lesions in the lungs. The pretreatment human chorionic gonadotropin (HCG) level was 84,000 mIU/ml and her FIGO risk factor score was 8 (high risk group). The EMA/CO regimen was administered as first line chemotherapy and the patient achieved complete remission after 7 courses. Although early onset postpartum hemorrhage is due to complication of delivery, but gestational trophoblastic disease (GTD) may be occurred and assessment of human chorionic gonadotropin could be help to early diagnose of GTD.
绒毛膜癌是一种可治愈的恶性肿瘤,约50%发生于足月妊娠后,这种类型的妊娠滋养细胞疾病(GTD)预后较差。一项研究中报道的足月妊娠后最早发生绒毛膜癌的时间是分娩后3周,但在本研究中,绒毛膜癌在分娩后2周被诊断出来。一名28岁、孕2产2的妇女足月分娩了一名健康婴儿。分娩10天后出现频繁的阴道出血。入院时,她肺部有病变。治疗前的人绒毛膜促性腺激素(HCG)水平为84,000 mIU/ml,其国际妇产科联盟(FIGO)危险因素评分为8分(高危组)。采用EMA/CO方案作为一线化疗,患者在7个疗程后实现完全缓解。虽然产后早期出血是分娩的并发症,但可能会发生妊娠滋养细胞疾病(GTD),检测人绒毛膜促性腺激素有助于早期诊断GTD。